Avenue Therapeutics's market cap is currently $2.42M. The company's EPS TTM is $0.105; its P/E ratio is ―; Avenue Therapeutics is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
